A CINful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
Affiliation
Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.Issue Date
2020
Metadata
Show full item recordCitation
Bultitude WP, Schellekens J, Szydlo RM, Anthias C, Cooley SA, Miller JS, et al. Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML. Bone Marrow Transplant. 2020.Journal
Embo Molecular MedicineDOI
10.15252/emmm.202012017PubMed ID
32072755Additional Links
https://dx.doi.org/10.15252/emmm.202012017Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.15252/emmm.202012017
Scopus Count
Collections
Related articles
- Targeting the CINful genome: Strategies to overcome tumor heterogeneity.
- Authors: Cunningham CE, MacAuley MJ, Yadav G, Vizeacoumar FS, Freywald A, Vizeacoumar FJ
- Issue date: 2019 Oct
- Acquisition of chromosome instability is a mechanism to evade oncogene addiction.
- Authors: Salgueiro L, Buccitelli C, Rowald K, Somogyi K, Kandala S, Korbel JO, Sotillo R
- Issue date: 2020 Mar 6
- Non-oncogene dependencies: Novel opportunities for cancer therapy.
- Authors: Di Marco T, Mazzoni M, Greco A, Cassinelli G
- Issue date: 2024 Oct
- At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC.
- Authors: Otano I, Ucero AC, Zugazagoitia J, Paz-Ares L
- Issue date: 2023 Mar
- Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
- Authors: Ito RE, Oneyama C, Aoki K
- Issue date: 2021